Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
8Customers
3Debt Items
20Related Chains
Source-Backed Evidence Depth
Burning Rock Biotech Limited (BNR) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
16Total relationships
2Distinct source URLs
4High confidence
0.759Average confidence
2026-10-28Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from GRAL graph: ess tests, operate our laboratory, delay our clinical studies, and damage our relationships with our customers. We could also be exposed to potential lawsuits…
Reciprocal relationship from IH graph: ther information on our critical accounting policies, see Note 2 to our consolidated financial statements. We believe the following accounting policies involve …
Reciprocal relationship from YDES graph: ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Nova…
Reciprocal relationship from YDESW graph: Reciprocal relationship from BNR graph: Reciprocal relationship from YDESW graph: ontributed approximately 53.7% of the Company’s total revenue. For the year…
Reciprocal relationship from JNJ graph: Reciprocal relationship from BNR graph: ays (1) For the year ended December 31, 2025. The design and performance of OncoScreen ™ Plus and OncoCompass ™ Plus ha…
ays (1) For the year ended December 31, 2025. The design and performance of OncoScreen ™ Plus and OncoCompass ™ Plus have been endorsed by their adoption in over 20 clinical trials and studies. For e…
MS-PE
Morgan Stanley
72%
Reciprocal relationship from MS-PE graph: Reciprocal relationship from BNR graph: e information contained in any notice of a shareholders’ meeting received by the depositary from us. I. Subsidiary In…
e information contained in any notice of a shareholders’ meeting received by the depositary from us. I. Subsidiary Information Not applicable. 147 Table of Contents J. Annual Report to Security Holde…
Reciprocal relationship from MYGN graph: Reciprocal relationship from BNR graph: Reciprocal relationship from MYGN graph: Reciprocal relationship from BNR graph: ays (1) For the year ended December 3…
ays (1) For the year ended December 31, 2025. The design and performance of OncoScreen ™ Plus and OncoCompass ™ Plus have been endorsed by their adoption in over 20 clinical trials and studies. For e…
Reciprocal relationship from YDESW graph: ontributed approximately 53.7% of the Company’s total revenue. For the year ended December 31, 2024, the Company’s top two corporate customers, Alcon and Nov…
Reciprocal relationship from ZTEK graph: Reciprocal relationship from BNR graph: Reciprocal relationship from ZTEK graph: Reciprocal relationship from BNR graph: Reciprocal relationship from ZTEK gra…
Burning Rock Biotech Limited Debt Obligations
Instrument
Description
Confidence
Evidence
BNR-DEBT-8308
Warrants outstanding: 0
90%
xbrl warrant detail from xbrl 2022-12-31.
BNR-DEBT-8309
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
BNR-DEBT
Debt stack $6.4M
90%
Market cache reports total debt of $6.4M.
Burning Rock Biotech Limited Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Burning Rock Biotech Limited.
Burning Rock Biotech Limited Ownership
Holder
Name
Confidence
Evidence
BNR-OWNER-BARCLAYS-PLC
BARCLAYS PLC
90%
13F overlay lists BARCLAYS PLC as top holder; 1 tracked holders.
Burning Rock Biotech Limited Extended Supply Chain Network